Vycor Medical, Inc. (VYCO)
USD 0.07
(24.05%)
USD 0.07
(24.05%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.31 Million USD | 21.56% |
| 2022 | 1.08 Million USD | -13.98% |
| 2021 | 1.25 Million USD | 24.63% |
| 2020 | 1 Million USD | -24.38% |
| 2019 | 1.33 Million USD | -0.35% |
| 2018 | 1.33 Million USD | 15.71% |
| 2017 | 1.15 Million USD | -8.69% |
| 2016 | 1.26 Million USD | 30.12% |
| 2015 | 974.51 Thousand USD | -10.92% |
| 2014 | 1.09 Million USD | 16.94% |
| 2013 | 935.54 Thousand USD | -8.79% |
| 2012 | 1.02 Million USD | 29.01% |
| 2011 | 795.1 Thousand USD | 197.0% |
| 2010 | 267.71 Thousand USD | 51.62% |
| 2009 | 176.56 Thousand USD | 51.09% |
| 2008 | 116.85 Thousand USD | 4600.64% |
| 2007 | 2486.00 USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 285.08 Thousand USD | 7.08% |
| 2024 Q2 | 356.23 Thousand USD | 30.18% |
| 2023 Q4 | 266.22 Thousand USD | -3.63% |
| 2023 Q1 | 330.19 Thousand USD | 41.04% |
| 2023 Q2 | 442.97 Thousand USD | 34.15% |
| 2023 Q3 | 276.25 Thousand USD | -37.63% |
| 2023 FY | 1.31 Million USD | 21.56% |
| 2022 FY | 1.08 Million USD | -13.98% |
| 2022 Q1 | 280.42 Thousand USD | 15.9% |
| 2022 Q2 | 300.03 Thousand USD | 6.99% |
| 2022 Q3 | 267.77 Thousand USD | -10.75% |
| 2022 Q4 | 234.11 Thousand USD | -12.57% |
| 2021 FY | 1.25 Million USD | 24.63% |
| 2021 Q3 | 296.94 Thousand USD | -34.32% |
| 2021 Q4 | 241.94 Thousand USD | -18.52% |
| 2021 Q2 | 452.09 Thousand USD | 69.15% |
| 2021 Q1 | 267.27 Thousand USD | 3.8% |
| 2020 Q3 | 235.37 Thousand USD | 5.18% |
| 2020 Q1 | 312.15 Thousand USD | -0.86% |
| 2020 Q2 | 223.77 Thousand USD | -28.31% |
| 2020 Q4 | 257.49 Thousand USD | 9.4% |
| 2020 FY | 1 Million USD | -24.38% |
| 2019 Q3 | 314.78 Thousand USD | -19.49% |
| 2019 FY | 1.33 Million USD | -0.35% |
| 2019 Q1 | 314.46 Thousand USD | -17.22% |
| 2019 Q2 | 390.98 Thousand USD | 24.33% |
| 2019 Q4 | 314.86 Thousand USD | 0.03% |
| 2018 Q1 | 295.75 Thousand USD | 59.49% |
| 2018 FY | 1.33 Million USD | 15.71% |
| 2018 Q2 | 254.67 Thousand USD | -13.89% |
| 2018 Q4 | 379.88 Thousand USD | -7.21% |
| 2018 Q3 | 409.41 Thousand USD | 60.76% |
| 2017 Q3 | 323.74 Thousand USD | 20.69% |
| 2017 FY | 1.15 Million USD | -8.69% |
| 2017 Q4 | 185.43 Thousand USD | -42.72% |
| 2017 Q2 | 268.23 Thousand USD | -29.49% |
| 2017 Q1 | 380.42 Thousand USD | 20.54% |
| 2016 FY | 1.26 Million USD | 30.12% |
| 2016 Q4 | 315.6 Thousand USD | 9.49% |
| 2016 Q1 | 332.84 Thousand USD | 45.34% |
| 2016 Q3 | 288.26 Thousand USD | -13.0% |
| 2016 Q2 | 331.32 Thousand USD | -0.46% |
| 2015 Q1 | 276.86 Thousand USD | 20.91% |
| 2015 FY | 974.51 Thousand USD | -10.92% |
| 2015 Q3 | 216.6 Thousand USD | -14.06% |
| 2015 Q2 | 252.03 Thousand USD | -8.97% |
| 2015 Q4 | 229.01 Thousand USD | 5.73% |
| 2014 Q2 | 262.77 Thousand USD | -16.62% |
| 2014 Q4 | 228.97 Thousand USD | -20.22% |
| 2014 Q3 | 286.99 Thousand USD | 9.22% |
| 2014 Q1 | 315.16 Thousand USD | 27.6% |
| 2014 FY | 1.09 Million USD | 16.94% |
| 2013 Q2 | 207.06 Thousand USD | 2.68% |
| 2013 Q4 | 247 Thousand USD | -11.73% |
| 2013 Q3 | 279.82 Thousand USD | 35.14% |
| 2013 Q1 | 201.65 Thousand USD | -20.19% |
| 2013 FY | 935.54 Thousand USD | -8.79% |
| 2012 Q3 | 194.74 Thousand USD | -13.5% |
| 2012 Q2 | 225.13 Thousand USD | -36.25% |
| 2012 Q4 | 252.66 Thousand USD | 29.74% |
| 2012 Q1 | 353.17 Thousand USD | -4.61% |
| 2012 FY | 1.02 Million USD | 29.01% |
| 2011 Q1 | 122.74 Thousand USD | 35.58% |
| 2011 Q2 | 107.13 Thousand USD | -12.72% |
| 2011 Q3 | 194.98 Thousand USD | 81.99% |
| 2011 Q4 | 370.24 Thousand USD | 89.89% |
| 2011 FY | 795.1 Thousand USD | 197.0% |
| 2010 Q3 | 59.34 Thousand USD | -10.14% |
| 2010 Q2 | 66.04 Thousand USD | 27.52% |
| 2010 Q1 | 51.78 Thousand USD | 31.46% |
| 2010 FY | 267.71 Thousand USD | 51.62% |
| 2010 Q4 | 90.53 Thousand USD | 52.56% |
| 2009 FY | 176.56 Thousand USD | 51.09% |
| 2009 Q2 | 36.97 Thousand USD | -38.98% |
| 2009 Q3 | 39.61 Thousand USD | 7.15% |
| 2009 Q1 | 60.58 Thousand USD | -46.78% |
| 2009 Q4 | 39.39 Thousand USD | -0.56% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q4 | 113.84 Thousand USD | 3679.75% |
| 2008 Q3 | 3012.00 USD | 0.0% |
| 2008 FY | 116.85 Thousand USD | 4600.64% |
| 2008 Q2 | - USD | 0.0% |
| 2007 FY | 2486.00 USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 466.38 Thousand USD | -182.094% |
| IR-Med Inc. | -17 Thousand USD | 7839.141% |
| Polarean Imaging plc | 335.48 Thousand USD | -292.167% |
| Medical Supply International USA, Inc. | 1.75 Million USD | 25.191% |
| Avitar, Inc. | 836.7 Thousand USD | -57.243% |
| AVITA Medical, Inc. | 41.68 Million USD | 96.844% |
| Manhattan Scientifics, Inc. | -1000.00 USD | 131665.4% |
| Össur hf. | 485.57 Million USD | 99.729% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 773.586% |
| QHSLab, Inc. | 793.6 Thousand USD | -65.782% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 485.57 Million USD | 99.729% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | 92.143% |
| Escalon Medical Corp. | 5.14 Million USD | 74.434% |
| Aurora Spine Corporation | 8.21 Million USD | 83.978% |
| BrainsWay Ltd. | 23.09 Million USD | 94.302% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 105.1 Thousand USD | -1151.776% |
| Hamilton Thorne Ltd. | 35.08 Million USD | 96.25% |
| Vivos Inc. | -6036.00 USD | 21896.786% |
| MicroPort Scientific Corporation | 532.09 Million USD | 99.753% |
| Kelyniam Global, Inc. | 2.03 Million USD | 35.383% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 273.858% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | -2224.723% |
| Nanomix Corporation | -69.45 Thousand USD | 1994.172% |
| Theraclion SA | -1.08 Million USD | 221.776% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | -123.922% |
| Positron Corporation | -353.46 Thousand USD | 472.216% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | -25.839% |
| Lombard Medical, Inc. | 955 Thousand USD | -37.765% |
| ALR Technologies Inc. | 4945.00 USD | -26505.743% |
| Stratec SE | 71.58 Million USD | 98.162% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 10298.868% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -537.371% |
| SANUWAVE Health, Inc. | 14.36 Million USD | 90.84% |
| VMS Rehab Systems, Inc. | -10.44 USD | 12602149.808% |
| Guided Therapeutics, Inc. | 36 Thousand USD | -3554.594% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | -389.859% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | -8000.00 USD | 16545.675% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | -20.256% |
| Urologix, Inc. | 6.09 Million USD | 78.407% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 515.438% |
| SS Innovations International, Inc. | 713.44 Thousand USD | -84.408% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | 99.966% |
| NIOX Group Plc | 28.13 Million USD | 95.323% |
| Fuse Medical, Inc. | 10.73 Million USD | 87.743% |
| Broncus Holding Corporation | 7.22 Million USD | 81.795% |
| Brain Scientific Inc. | 54.32 Thousand USD | -2321.821% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | -64.547% |
| Health Logic Interactive Inc. | - USD | -Infinity% |